PetVivo Holdings, Inc. (PETV)
- Previous Close
0.8000 - Open
0.8000 - Bid --
- Ask --
- Day's Range
0.7700 - 0.8197 - 52 Week Range
0.3300 - 2.9000 - Volume
17,604 - Avg. Volume
51,242 - Market Cap (intraday)
13.746M - Beta (5Y Monthly) 2.10
- PE Ratio (TTM)
-- - EPS (TTM)
-0.8500 - Earnings Date Jun 27, 2024 - Jul 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
www.petvivo.comRecent News: PETV
Performance Overview: PETV
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PETV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PETV
Valuation Measures
Market Cap
13.75M
Enterprise Value
15.06M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.73
Price/Book (mrq)
15.36
Enterprise Value/Revenue
14.40
Enterprise Value/EBITDA
-1.43
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-207.74%
Return on Equity (ttm)
-1,266.46%
Revenue (ttm)
1.05M
Net Income Avi to Common (ttm)
-10.63M
Diluted EPS (ttm)
-0.8500
Balance Sheet and Cash Flow
Total Cash (mrq)
80.08k
Total Debt/Equity (mrq)
156.25%
Levered Free Cash Flow (ttm)
-4.02M